BioSpace News Archive

Business

Akebia Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights

Akebia to host conference call on May 8 at 8:30 a.m. ET.

May 8, 2023
·
13 min read
Business

Marker Therapeutics Appoints Monic Stuart, M.D., as Chief Medical Officer

Marker Therapeutics, Inc. today announced the appointment of Monic Stuart, M.D., as its new Chief Medical Officer.

May 8, 2023
·
5 min read
BioCapital

Biosion Presents Discovery and Development Data at PEGS for its Anti-CD40 Agonistic Antibody

Biosion USA , Inc. today announced the upcoming presentation of discovery and development data for BSI-038, an anti-CD40 agonistic antibody at the PEGS Boston conference to be held from May 15 to 19, 2023.

May 8, 2023
·
2 min read
Business

Zevra Announces Board of Directors and Leadership Changes

Zevra Therapeutics, Inc. today announced changes to the Company’s Board of Directors (“Board”) and leadership. At the Company’s recent 2023 Annual Meeting of Stockholders (“Annual Meeting”), Zevra shareholders elected John B. Bode, Douglas W. Calder and Corey Watton to Zevra’s Board.

May 8, 2023
·
5 min read
Business

Nephros Announces CEO Retirement and Succession Plan

Nephros, Inc. today announced that Andy Astor, President and Chief Executive Officer, will retire in the coming months, and that Robert Banks will be named President and Chief Executive Officer effective on the first business day after the filing of Nephros’ Form 10-Q for the quarter ended March 31, 2023.

May 8, 2023
·
4 min read